Trial site
Canberra Hospital
- 30running trials
- 12closed trials
The trials here
What the 42 trials at this site are about, from their registry records.
- Conditions
- Chronic kidney disease6 trials
- Heart failure6 trials
- Coronary artery disease4 trials
- Lung cancer4 trials
- Stroke4 trials
- Multiple myeloma3 trials
- Obesity3 trials
- Type 2 diabetes3 trials
- Endometrial cancer2 trials
- Idiopathic pulmonary fibrosis2 trials
- Immune thrombocytopenia (ITP)2 trials
- Type 1 diabetes2 trials
- and 16 more
- Phase
- Phase 329 trials
- Phase 24 trials
- Phase 2/32 trials
- Phase 1/21 trial
- Phase 41 trial
- Status
- Recruiting15 trials
- Active, not recruiting12 trials
- Completed10 trials
- Not yet recruiting3 trials
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Boehringer Ingelheim5 trials
- Amgen4 trials
- Eli Lilly and Company3 trials
- BeOne Medicines2 trials
- Canadian Cancer Trials Group2 trials
- and 24 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Recruiting
Recruiting
Recruiting
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Recruiting
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Active, not recruiting
Active, not recruiting
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
Active, not recruiting
Recruiting
Active, not recruiting
Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients
Active, not recruiting
The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure3 recruiting
- Multiple myeloma3 recruiting
- Coronary artery disease2 recruiting
- Immune thrombocytopenia (ITP)2 recruiting
- Lung cancer2 recruiting
- Obesity2 recruiting
- Stroke2 recruiting
- Type 2 diabetes2 recruiting
- Aortic stenosis1 recruiting
- Atrial fibrillation1 recruiting
- Chronic kidney disease1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- High blood pressure1 recruiting
- Ventricular tachycardia1 recruiting
Closed trials
Withdrawn
REmission in Membranous Nephropathy International Trial (REMIT)
Completed
Completed
Terminated
Completed
Closed-loop Insulin Delivery In Type 1 Diabetes Pregnancies (CIRCUIT)
Completed
DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma
Completed
Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease
Completed
Completed
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)
Completed
Completed
Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease
Completed
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
Site data: ClinicalTrials.govUpdated 18 Nov 2026